DSPE-PEG-ClTx
1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol-ClTx
						| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product | 
|---|---|---|---|---|
| R-DS-0038 | 50mg | 600.00 | + Add to cart  | 
																					|
| R-DS-0038 | 100mg | 900.00 | + Add to cart  | 
																					|
										
  | 
								||||
Product description
							Liposomes can passively enter tumor tissue through enhanced retention effect (EPR).Compared with radiotherapy and chemotherapy alone,liposomes have certain clinical treatment advantages.However, due to the rapid blood flow,liposomes can not stay in the tumor site for a long time after entering the body through intravenous injection.However,the targeted liposome prepared by connecting peptide on the surface of liposome can reach the target site immediately after intravenous injection and stay in the tumor site for a long time.The drug released from the liposome can improve the therapeutic effect of tumor.
| Appearance | Off-white/brown solid or viscous liquid depends on molecular weight | 
|---|---|
| PEG Molecular Weight | 1000,2000,3400,5000,10000 Dalton | 
| substitution by NMR | >95% | 
| PDI by GPC | <1.5 | 
| Solubility | Organic solvents | 
| Storage | -20℃, protected from light and moisture | 
| Transportation | 4-25℃ temperature for up to 2 weeks | 
| Stability | 1 year | 
Document
							Related Product
							
						
Items-$0.00

Email:
Tel.:
msds---DSPE-PEG-ClTx 
                    RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                
                    Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China 
                
                    Tel:  02988811435
                
                    Fax: (86-29)8881-1435
                
                    Email: sales@ruixibiotech.com
                
                    Web: http://www.ruixibiotech.com    
					
							
                

